EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0603
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

TM4SF1 as a Prognostic Marker of Pancreatic Ductal Adenocarcinoma Is Involved in Migration and Invasion of Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Tetraspanin CD151 Is a Novel Prognostic Marker in Poor Outcome Endometrial Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE
Multidisciplinary
2017English

Low Expression of Aldehyde Deyhdrogenase 1A1 (ALDH1A1) Is a Prognostic Marker for Poor Survival in Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

ATPase Inhibitory Factor 1 Is a Potential Prognostic Marker for the Migration and Invasion of Glioma

Oncology Letters
Cancer ResearchOncology
2015English

RAD21 Cohesin Overexpression Is a Prognostic and Predictive Marker Exacerbating Poor Prognosis in KRAS Mutant Colorectal Carcinomas

British Journal of Cancer
Cancer ResearchOncology
2014English

MicroRNA-153 Acts as a Prognostic Marker in Gastric Cancer and Its Role in Cell Migration And invasion

OncoTargets and Therapy
OncologyPharmacology
2015English

NOTCH4 Is a Novel Prognostic Marker That Correlates With Colorectal Cancer Progression and Prognosis

Journal of Cancer
Oncology
2018English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy